申请人:Genentech, Inc.
公开号:US20170137393A1
公开(公告)日:2017-05-18
Compounds of the formula I:
or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, X
1
, X
2
, X
3
, X
4
, Y, Z, A, R
1
, R
2
, R
3
, R
4
, R
5
R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
and R
13
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis, muscular sclerosis and psoriasis.